INTRODUCTION: Hypokinetic dysarthria (HD) is a common motor speech symptom of Parkinson's disease (PD) which does not respond well to PD treatments. We investigated short-term effects of transcranial direct current stimulation (tDCS) on HD in PD using acoustic analysis of speech. Based on our previous studies we focused on stimulation of the right superior temporal gyrus (STG) - an auditory feedback area. METHODS: In 14 PD patients with HD, we applied anodal, cathodal and sham tDCS to the right STG using a cross-over design. A protocol consisting of speech tasks was performed prior to and immediately after each stimulation session. Linear mixed models were used for the evaluation of the effects of each stimulation condition on the relative change of acoustic parameters. We also performed a simulation of the mean electric field induced by tDCS. RESULTS: Linear mixed model showed a statistically significant effect of the stimulation condition on the relative change of median duration of silences longer than 50 ms (p = 0.015). The relative change after the anodal stimulation (mean = -5.9) was significantly lower as compared to the relative change after the sham stimulation (mean = 12.8), p = 0.014. We also found a correlation between the mean electric field magnitude in the right STG and improvement of articulation precision after anodal tDCS (R = 0.637; p = 0.019). CONCLUSIONS: The exploratory study showed that anodal tDCS applied over the auditory feedback area may lead to shorter pauses in a speech of PD patients.

Applied Neuroscience Research Group Central European Institute of Technology CEITEC Masaryk University Brno Czech Republic

Department of Telecommunications Brno University of Technology Brno Czech Republic

Faculty of Medicine and St Anne's University Hospital 1st Department of Neurology Brno Czech Republic

Zobrazit více v PubMed

Baudouin R, Lechien JR, Carpentier L, et al. Deep brain stimulation impact on Voice and Speech Quality in Parkinson’s Disease: a systematic review. Otolaryngology–Head Neck Surg. 2023;168:307–318. doi: 10.1177/01945998221120189. PubMed DOI

Baumann A, Nebel A, Granert O, et al. Neural correlates of Hypokinetic Dysarthria and mechanisms of effective Voice treatment in Parkinson Disease. Neurorehabil Neural Repair. 2018;32:1055–1066. doi: 10.1177/1545968318812726. PubMed DOI

Biundo R, Weis L, Facchini S, et al. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord. 2014;20:394–399. doi: 10.1016/J.PARKRELDIS.2014.01.009. PubMed DOI

Brabenec L, Mekyska J, Galaz Z, Rektorova I. Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm. 2017;124:303–334. doi: 10.1007/s00702-017-1676-0. PubMed DOI

Brabenec L, Klobusiakova P, Barton M, et al. Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson’s disease. Parkinsonism Relat Disord. 2019;61:187–192. doi: 10.1016/j.parkreldis.2018.10.011. PubMed DOI

Brabenec L, Klobusiakova P, Simko P, et al. Non-invasive brain stimulation for speech in Parkinson’s disease: a randomized controlled trial. Brain Stimul. 2021;14:571–578. doi: 10.1016/J.BRS.2021.03.010. PubMed DOI

Brunoni AR, Nitsche MA, Bolognini N, et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012;5:175–195. doi: 10.1016/j.brs.2011.03.002. PubMed DOI PMC

Cavallieri F, Budriesi C, Gessani A et al (2021) Dopaminergic treatment effects on Dysarthric Speech: acoustic analysis in a cohort of patients with Advanced Parkinson’s Disease. Front Neurol 11. 10.3389/FNEUR.2020.616062/FULL PubMed PMC

Dobbs B, Pawlak N, Biagioni M et al (2018) Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson’s disease. J Neuroeng Rehabil 15. 10.1186/S12984-018-0457-9 PubMed PMC

Klobusiakova P, Mekyska J, Brabenec L, et al. Articulatory network reorganization in Parkinson’s disease as assessed by multimodal MRI and acoustic measures. Parkinsonism Relat Disord. 2021;84:122–128. doi: 10.1016/j.parkreldis.2021.02.012. PubMed DOI

Kostalova M (2013) Test 3F Dysartrický profil – normativní hodnoty řeči v češtině. Cesk Slov Neurol N 614–618

Liu D, Chang Y, Dai G, et al. Right, but not left, posterior superior temporal gyrus is causally involved in vocal feedback control. NeuroImage. 2023;278:120282. doi: 10.1016/J.NEUROIMAGE.2023.120282. PubMed DOI

New AB, Robin Da, Parkinson AL, et al. The intrinsic resting state voice network in Parkinson’s disease. Hum Brain Mapp. 2015;36:1951–1962. doi: 10.1002/hbm.22748. PubMed DOI PMC

Ni R, Yuan Y, Yang L et al (2022) Novel non-invasive transcranial electrical stimulation for Parkinson’s Disease. Front Aging Neurosci 14. 10.3389/FNAGI.2022.880897/FULL PubMed PMC

Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 2008;1:206–223. doi: 10.1016/j.brs.2008.06.004. PubMed DOI

Pinto S, Ferraye M, Espesser R, et al. Stimulation of the pedunculopontine nucleus area in Parkinson’s disease: effects on speech and intelligibility. Brain. 2014;137:2759–2772. doi: 10.1093/brain/awu209. PubMed DOI

Pinto S, Nebel A, Rau J, et al. Results of a Randomized Clinical Trial of Speech after Early Neurostimulation in Parkinson’s Disease. Mov Disord. 2023;38:212–222. doi: 10.1002/MDS.29282. PubMed DOI

Postuma RB, Berg D, Adler CH, et al. The new definition and diagnostic criteria of Parkinson’s disease. Lancet Neurol. 2016;15:546–548. doi: 10.1016/S1474-4422(16)00116-2. PubMed DOI

Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson’s disease. Expert Rev Neurother. 2008;8:297–309. doi: 10.1586/14737175.8.2.297. PubMed DOI

Rusz J, Tykalová T, Klempíř J, et al. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm (Vienna) 2016;123:379–387. doi: 10.1007/s00702-016-1515-8. PubMed DOI

Rusz J, Tykalova T, Novotny M, et al. Defining Speech subtypes in De Novo Parkinson Disease: response to long-term levodopa therapy. Neurology. 2021;97:e2124–e2135. doi: 10.1212/WNL.0000000000012878. PubMed DOI

Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm. 2010;117:197–205. doi: 10.1007/s00702-009-0351-5. PubMed DOI

Skodda S, Grönheit W, Schlegel U, et al. Effect of subthalamic stimulation on voice and speech in Parkinson’s disease: for the better or worse? Front Neurol. 2014;4:1–9. doi: 10.3389/fneur.2013.00218. PubMed DOI PMC

Thielscher A, Antunes A, Saturnino GB Field modeling for transcranial magnetic stimulation: A useful tool to understand the physiological effects of TMS? In: 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology, Society (2015) (EMBC). IEEE, pp 222–225 PubMed

Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76:80–86. doi: 10.1212/WNL.0b013e318203e7d0. PubMed DOI PMC

Tripoliti E, Limousin P, Foltynie T, et al. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov Disord. 2014;29:532–538. doi: 10.1002/mds.25816. PubMed DOI PMC

Tsuboi T, Watanabe H, Tanaka Y, et al. Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. 2014;86:1–9. doi: 10.1136/jnnp-2014-308043. PubMed DOI

Tykalova T, Rusz J, Cmejla R, et al. Effect of dopaminergic medication on speech dysfluency in Parkinson’s disease: a longitudinal study. J Neural Transm (Vienna) 2015;122:1135–1142. doi: 10.1007/s00702-015-1363-y. PubMed DOI

Yuan F, Guo X, Wei X, et al. Lee Silverman Voice Treatment for Dysarthria in patients with Parkinson’s disease: a systematic review and meta-analysis. Eur J Neurol. 2020;2020:1957–1970. doi: 10.1111/ene.14399. PubMed DOI